Laurie Keating Net Worth & Insider Trades

Laurie Keating - EVP, Alnylam Pharmaceuticals, Inc

As of August 9, 2021

What is Laurie Keating's Net Worth?

The current estimated net worth of Alnylam Pharmaceuticals, Inc's EVP, Laurie Keating, is estimated to be about $32.63M . Laurie Keating owns about 5,566 units of Alnylam Pharmaceuticals, Inc common stock. In the last 6 years at Alnylam Pharmaceuticals, Inc, Laurie Keating has sold an estimated value of $31.49M worth.

What is Laurie Keating's Past Insider Trading?

Laurie Keating's largest purchase order was 35,750 units , worth over $3.12M on July 14, 2020. Laurie Keating's largest sale order was 47,250 units , worth over $7.59M on July 14, 2020. In total, Laurie Keating has made about 35 transactions over 6 years of their time at Alnylam Pharmaceuticals, Inc. Laurie Keating usually trades in February, with the busiest year in 2021. The most recent transaction was a sale order of 10,000 units , worth over $1.89M on August 9, 2021.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Laurie Keating's' Mailing Address?

  • Mailing address is 300 Third Street Cambridge MA 02142 MA

What are Alnylam Pharmaceuticals, Inc's Past Insider Trades?

Alnylam Pharmaceuticals, Inc's most recent insider trade came on August 17, 2022 by Phillip A Sharp who sold 33,670 units worth $7.76M . In the last 18 years, insiders at Alnylam Pharmaceuticals, Inc have sold an estimated value of $502.26M and bought an estimated value of $247.3M worth of shares. Insider trading is most common in June, with the busiest year in 2014. The most active traders at the company are John Maraganore, Chief Executive Officer,  Akshay Vaishnaw, President,  and Barry E Greene, President .

POLARIS INDUSTRIES INC/MN Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1